InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
29%
T+90 mean return
-3.8%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by LAWLIS V BRYAN, Director. Officer active across 2 companies, notably Biomarin Pharmaceutical INC. In total, 11 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €14k. History available since 25 May 2021. The latest transaction was filed on 9 May 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations11 total
13,300 shares@ US$1.17812.5% of flowCommon StockSEC:0000886744-25-000013:0
Ideal exit: 3 Feb 2026 (T+270)
35,000 shares@ US$1.9455.9% of flowCommon StockSEC:0000950170-24-061615:0
4,190 shares0Common StockSEC:0001209191-23-031973:0
35,000 shares@ US$1.1031.6% of flowCommon StockSEC:0001062993-23-010852:0
8,500 shares@ US$67.8155.4% of flowCommon StockSEC:0001209191-23-023062:0
4,980 shares0Common StockSEC:0001567619-22-011796:0
4,250 shares@ US$37.460.0013% mcap34.6% of flowCommon StockSEC:0001567619-22-008633:0
4,250 shares@ US$37.46100.0% of flowCommon StockSEC:0001567619-22-001334
4,250 shares@ US$37.460.0012% mcap32.7% of flowCommon StockSEC:0001567619-22-001334:0
5,120 shares0Common StockSEC:0001567619-21-011314:0
5,120 shares0Common StockSEC:0001567619-21-011314
11 of 11 declarations
About LAWLIS V BRYAN
Bryan V. Lawlis is a Director at BIOMARIN PHARMACEUTICAL INC. As a board member, he provides his expertise to guide the company's strategy and ensure good governance. His experience is valuable for BIOMARIN.
